Authors:
TRUNET PF
VREELAND F
ROYCE C
CHAUDRI HA
COOPER J
BHATNAGAR AS
Citation: Pf. Trunet et al., CLINICAL USE OF AROMATASE INHIBITORS IN THE TREATMENT OF ADVANCED BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 61(3-6), 1997, pp. 241-245
Authors:
SIOUFI A
GAUDUCHEAU N
PINEAU V
MARFIL F
JAOUEN A
CARDOT JM
GODBILLON J
CZENDLIK C
HOWALD H
PFISTER C
VREELAND F
Citation: A. Sioufi et al., ABSOLUTE BIOAVAILABILITY OF LETROZOLE IN HEALTHY POSTMENOPAUSAL WOMEN, Biopharmaceutics & drug disposition, 18(9), 1997, pp. 779-789
Authors:
BURRIS H
IRVIN R
KUHN J
KALTER S
SMITH L
SHAFFER D
FIELDS S
WEISS G
ECKARDT J
RODRIGUEZ G
RINALDI D
WALL J
COOK G
SMITH S
VREELAND F
BAYSSAS M
LEBAIL N
VONHOFF D
Citation: H. Burris et al., PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR6-HOUR INTRAVENOUS-INFUSION, Journal of clinical oncology, 11(5), 1993, pp. 950-958
Authors:
BALTZER L
KRIS MG
TYSON LB
RIGAS JR
VREELAND F
PISTERS KMW
Citation: L. Baltzer et al., DOSE-RANGING ANTIEMETIC EVALUATION OF THE SEROTONIN ANTAGONIST RG-12915 IN PATIENTS RECEIVING ANTICANCER CHEMOTHERAPY, Cancer, 72(9), 1993, pp. 2695-2699